Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
PLoS One ; 14(2): e0210737, 2019.
Article in English | MEDLINE | ID: mdl-30721235

ABSTRACT

The arsenic contamination of ground water in visceral leishmaniasis (VL) endemic areas in Bihar, India leads to human exposure through drinking water. Possibly, the consumed arsenic (As) accumulates in the tissues of VL patients, who subsequently internalize intracellular amastigotes to confer resistance against chemotherapy to the parasite, leading to modulation in the host's immune response. This hypothesis appears to be consistent with the in vitro findings that in arsenic-exposed parasites, the mitochondrial membrane potential became depolarized, whereas the reduced thiol and lactate production was overexpressed with enhanced glucose consumption; therefore, the reduced thiol possibly supports an immunosuppressive state in the host cells. This observation was well supported by the down-regulated expression of pro-inflammatory cytokines (IL-2, IL-12, IFN-γ, and TNF-α) with a suppressed anti-leishmanial function of macrophage (NO, ROS). In contrast, the pathophysiological mechanism of VL has received ample support by the promotion of Th2 cytokines (IL-4 and IL-10) in the presence of arsenic-exposed Leishmania parasites (LdAS). Dysfunction of mitochondria and the overexpression of lactate production raise the possibility of the Warburg effect being operative through the up-regulation of glucose consumption by parasites to enhance the energy production, possibly augmenting virulence. Therefore, we surmise from our data that arsenic exposure to Leishmania donovani modulates the immune response and infection pattern by impairing parasite function, which may affect the anti-leishmanial effect in VL.


Subject(s)
Arsenic/pharmacology , Leishmania donovani/immunology , Leishmaniasis, Visceral , Macrophages, Peritoneal , Animals , Cytokines/immunology , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/pathology , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/parasitology , Macrophages, Peritoneal/pathology , Mice , Nitric Oxide/immunology , Reactive Oxygen Species/immunology
3.
Cell Immunol ; 332: 51-57, 2018 10.
Article in English | MEDLINE | ID: mdl-30049412

ABSTRACT

Visceral leishmaniasis (VL) is a disease caused by protozoan species of the genus Leishmania and is transmitted through bites from the Phlebotomus sand fly; it is associated with considerable morbidity and mortality in many parts of world, including India. Reports on the protective role played by saliva proteins of Lutozomyia longipalpis, Phlebotomus papatasi and Phlebotomus duboscqi. are available. However, no studies have explored the salivary proteins of P. argentipes, which is the known proven vector for the transmission of VL in the Indian sub-continent. Herein we revealed the presence of two proteins of 14.2 and one protein of 13.6 kDa in Indian strain P. argentipes which is absolute identical to previously reported protein of SP15 family (PagSP01, PagSP02 and PagSP07) of P. argentipes of NIH colony, USA. In an experimental study on P. argentipes from Bihar, India, we demonstrated that a strong humoral and cellular immune response was triggered to reduce the concomitant Leishmania load in groups of immunized mice. The immunized group produced a considerable amount of IgG antibodies, and their splenocytes generated TH1 cytokines (IL-12, IFN-γ) with the support of delayed-type hypersensitivity (DTH) reactivity in such mice at the challenged site. We summarize from our data that some identical proteins to previous from SP15 family protein of 14.2 and 13.6 kDa molecular size, derived from Indian P. argentipes and reported its first time, can also be significant in resolution of VL infection after modulation of host protective T cell response in VL.


Subject(s)
Leishmania/immunology , Leishmaniasis, Visceral/immunology , Phlebotomus/immunology , Psychodidae/immunology , Saliva/immunology , Salivary Proteins and Peptides/immunology , Animals , Cytokines/immunology , Female , Immunity, Cellular/immunology , Immunity, Humoral/immunology , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C , Th1 Cells/immunology
4.
Cytokine ; 86: 79-85, 2016 10.
Article in English | MEDLINE | ID: mdl-27484246

ABSTRACT

Currently the main concerns regarding control of visceral leishmaniasis (VL) caused by L. donovani are immunosuppression, relating toxicity of anti-leishmanial drug and little development in appropriate vaccine and vector (P. argentipes) control. Reports available from ex-vivo studies reflect significance of vector salivary gland homogenate (SGH) in reverting immunosuppression of infected VL subjects and as such the immunogenic nature of SGH can be a strategy to modulate immune system and anti-leishmanial function to enable immune response to control the disease. Several related studies also identified a better utility of vector anti-saliva antibodies in achieving such effects by an adoptive transfer approach instead of direct stimulation with SGH protein. However, conclusive evidences on VL cases are far beyond satisfactory to suggest role of SGH into modulation of host immune response in VL subjects in India. This study was under taken to make comparison on change in cytokines (TH1 and TH2) response pattern and anti-leishmanial macrophage (Mϕ) function following stimulation of their PBMCS with SGH protein derived from P. argentipes sand fly vector for VL or anti SGH antibodies raised in rabbit. This study reports for the first time that L. donovani sensitized healthy subject demonstrates an up-regulated Interferon-γ (TH1) and down regulate Interleukin-10 (TH2) production following stimulation of their PBMCs by P. argentipes anti-saliva antibodies accompanied with an improvement in anti-leishmanial Mϕ function for nitric oxide (NO) production. Subsequent experiments suggest that P. argentipes based anti-SGH antibodies when used to stimulate LD infected PBMCs in healthy subjects resulted in better clearance of Leishmania amastigotes load compare to SGH protein. Possibly the immunogenic components of anti-saliva an antibody maintains the level of protective cytokine (INF-γ) and seems to restrict the infection by host protection by vector saliva.


Subject(s)
Antibodies/immunology , Leishmaniasis, Visceral/immunology , Macrophages/immunology , Phlebotomus/immunology , Salivary Glands/immunology , Th1 Cells/immunology , Animals , Cytokines/biosynthesis , Cytokines/immunology , Humans , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-10/genetics , Interleukin-10/immunology , Leishmania donovani/immunology , Leishmaniasis, Visceral/prevention & control , Leukocytes, Mononuclear/immunology , Macrophages/metabolism , Nitric Oxide/biosynthesis , Parasite Load , Phlebotomus/chemistry , Rabbits , Salivary Glands/chemistry , Salivary Proteins and Peptides/immunology
5.
Exp Parasitol ; 135(3): 595-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24076432

ABSTRACT

Anemia in kala-azar patients is a serious problem. The present study has addressed this problem with the hypothesis that as the Leishmania parasite is completely devoid of heme biosynthetic pathway, therefore the excessive use of heme by the parasites in the human patients can be one of the possible reason of anemia. We investigated that whether, the inability of Leishmania donovani to synthesize heme, can enforce Leishmania parasite to utilize heme derived from host sources in Indian KA patients. Patients had higher tendency of their macrophages to bind with Hb which was pronounced after sensitization with drug resistant Leishmania strain compared to sensitive.


Subject(s)
Anemia/parasitology , Heme/metabolism , Leishmania donovani/metabolism , Leishmaniasis, Visceral/complications , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Female , Hemoglobins/metabolism , Humans , Leishmaniasis, Visceral/metabolism , Leishmaniasis, Visceral/parasitology , Macrophages/metabolism , Male , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/metabolism , Severity of Illness Index
6.
J Commun Dis ; 40(4): 273-6, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19579720

ABSTRACT

The communication presents clinical response of cases of visceral leishmaniasis to treatment by two different brands of Amphotericin B. Fungizone was found to be slightly better than Amphotericin B, however, the difference is not statistically significant.


Subject(s)
Amphotericin B , Leishmania donovani/drug effects , Leishmaniasis, Visceral/drug therapy , Adolescent , Adult , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Animals , Child , Humans , Leishmania donovani/isolation & purification , Leishmaniasis, Visceral/parasitology , Leishmaniasis, Visceral/pathology , Mice , Spleen/drug effects , Spleen/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...